Hospitals and health systems looking to establish brand dominance, competitive distinction and clinical excellence in diabetes care can turn to a team of experts at Glytec dedicated to helping facilitate full adoption of best practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191016005087/en/
Glytec’s new Quality Team is partnering with healthcare organizations to achieve clinical excellence in diabetes care and glycemic management. “The programs we’re offering are designed not only to optimize the patient and the provider experience, but also to engage senior leadership on improvements in clinical and financial outcomes,” says Raymie McFarland, Vice President of Quality Initiatives. (Photo: Business Wire)
“With our new team, we’re delivering a very robust and broad array of services that address diabetes care and glycemic management at all levels, from the bedside to the c-suite,” says Raymie McFarland, Vice President of Quality Initiatives at Glytec. “The programs we’re offering are designed not only to optimize the patient and the provider experience, but also to engage senior leadership on improvements in clinical and financial outcomes.”
To schedule a complimentary consultation at the upcoming Becker’s CEO + CFO Roundtable, IHI National Forum or by phone, click here.
Glytec’s eGlycemic Management System® — a cloud-hosted, FDA-cleared software-as-a-medical device — is utilized by local and regional health systems throughout the country for insulin therapy optimization. The proprietary solution is proven to reduce severe hypoglycemia as much as 99.8 percent, 30-day readmissions as much as 68 percent, and average lengths of stay as much as 3.2 days. It is also proven to produce cost savings as high as $20,000 per licensed bed.
The company has directed many successful transitions from outdated practices using sliding-scale insulin to best practices using basal-bolus-correction insulin, as recommended by the American Diabetes Association, American Association of Clinical Endocrinologists, Society of Hospital Medicine and other authoritative sources.
“The great results our clients have seen are really the combined product of our technology plus our expertise,” says McFarland. “We’re not the typical vendor. We don’t just install software, train users and leave. We partner with our clients long-term, guiding and supporting them through the myriad challenges associated with clinical practice change.”
Members of Glytec’s Quality Initiatives team include:
Melanie Mabrey, DNP, ACNP-BC, BC-ADM, CDTC, FAANP, Vice President of Clinical Practice
Dr. Mabrey developed and served as director of the inpatient endocrine nurse practitioner program at Duke University Hospital and also started an endocrine/diabetes service at Duke Regional Hospital, where she served as associate medical director and maintains current clinical practice.
Valerie Garrett, MD, MPH, Executive Director of Quality Initiatives
Dr. Garrett is a hospitalist and former medical director of Mission Health’s diabetes center, where she led an interdisciplinary team charged with standardizing and improving glycemic management across the health system.
Jordan Messler, MD, SFHM, Executive Director of Quality Initiatives
Dr. Messler is a hospitalist and former chair of the Society of Hospital Medicine’s Quality and Patient Safety Committee, where he was active in several mentoring programs, including Project BOOST and Glycemic Control.
Paul Chidester, MD, Executive Director of Quality Initiatives
Dr. Chidester is the former (retired) vice president of medical affairs at Sentara Norfolk General Hospital. As the chair of Sentara Healthcare’s Glycemic Control Steering Committee, he spearheaded the system-wide standardization of glycemic protocols and directed multiple research studies.
Mary Gaines, RN, MSN, Director of Quality Initiatives
Mary is the former director of glycemic management at Florida Hospital System (now AdventHealth Orlando), where she designed and instituted a diverse spectrum of programs to achieve best practices, resulting in improvements to glucose control, nursing workflow and patient safety.
Betsy Kubacka, MSN, AGPCNP-BC, RDN, CDE, Director of Clinical Practice
Betsy is a former inpatient diabetes clinical coordinator for Hartford HealthCare, where she co-chaired the health system’s Endocrine Council and provided leadership on quality improvement, compliance, staff education, mentoring and technology programs.
Jennifer Crowe, MHA, CPHQ, ASQ-SSBB, Director of Quality Improvement
Jennifer is a former performance improvement manager for Palmetto Health (now Prisma Health-Midlands), where she directed multiple glycemic optimization initiatives. She is an ASQ Six Sigma Black Belt, NAHQ CPHQ certified, and experienced in Lean principles and the IHI model for improvement.
Founded in 2006, Glytec is the pioneer of digital therapeutics, improving the lives of people with diabetes by making insulin a more effective and accessible option for millions unable to achieve their treatment goals. The company’s patented eGlycemic Management System® is the only FDA-cleared software-as-a-medical-device (SaMD) platform to enable the mass personalization of insulin across the continuum of care: inpatient, outpatient and virtual settings alike. Glytec offers several comprehensive programs combining evidence-based decision support technologies with expert professional services proven to aid providers in achieving best practices and standardization while reducing hyperglycemia, hypoglycemia, A1C, readmissions, length of stay and cost. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information visit www.glytecsystems.com.